Evidence suggests that depletion of PRK1 and PRK2 in macrophages results in inflammasome‐dependent IL‐1β release, suggesting that these PRKs inhibit activation of the pyrin inflammasome (which forms in response to bacterial infection and induce interleukin [IL] release from macrophages to combat infection).33 This evidence concerns the gene PKN2 and bacterial infectious disease.